General Information of This Drug (ID: DMUR64T)

Drug Name
Lesinurad   DMUR64T
Synonyms
LESINURAD; 878672-00-5; RDEA594; Zurampic; RDEA 594; UNII-09ERP08I3W; RDEA-594; 2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid; 09ERP08I3W; AK323774; C17H14BrN3O2S; 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid; 2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid; 2-(5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid
Indication
Disease Entry ICD 11 Status REF
Hyperuricaemia 5C55.Y Approved [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

4 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Allopurinol + Lesinurad DCGOBYG Allopurinol Gout [2]
Febuxostat + Lesinurad DCAX8DV Febuxostat Tophaceous Gout [3]
Lesinurad + Naproxen DCU646T Naproxen Gout [4]
Lesinurad + Indomethacin DCY25NE Indomethacin Gout [4]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7673).
2 ClinicalTrials.gov (NCT01510158) Combining Lesinurad With Allopurinol in Inadequate Responders
3 ClinicalTrials.gov (NCT01510769) Combination Treatment Study in Subjects With Tophaceous Gout With Lesinurad and Febuxostat
4 ClinicalTrials.gov (NCT01884272) NSAID Drug Interaction Study